Introduction COPD is associated with a considerable degree of morbidity and mortality and has been shown to adversely affect quality of life. One of the aims of a large epidemiological study of COPD and occupation in Sheffield was to evaluate quality of life. Having previously presented data from our initial survey using the EQ-5D tool and self-reported COPD 1 , we now present data from the follow up phase of the population based study using the more detailed quality of life estimate SF-36v2 and COPD defined by spirometry.Methods A random population sample of 4000 Sheffield residents aged over 55 years was approached for study in 2007, along with a supplemental sample of 209 people with likely COPD recruited from a hospital physiology department. A detailed questionnaire recorded demographics, respiratory symptoms and diagnoses, smoking and occupational exposures. A proportion were re-visited in 2009e2010 for further spirometry and quality of life measure using the SF-36v2, which consists of 36 questions, divided into 8 domains, scores being converted to a scale from 0 to 100, the higher score indicating better health. Results 549 people participated in the follow up phase, of whom 361 completed the SF-36v2. Abstract P1 Figure 1 shows mean scores for each of four different categories relating to COPD (defined by GOLD level 1 spirometry) and ever exposure to vapours, gases, dust and fumes (VGDF) in the workplace. In all domains, the group with airways obstruction has lower mean values than those without, and those who also report exposure to VDGF at work have further reductions (p<0.05). Of the 103 people in this group who have airways obstruction, those who also self-report a diagnosis of COPD (n¼49) have significantly worse (p<0.05) quality of life than those who have no self-reported diagnosis.Abstract P1 Figure 1 Conclusions Those with GOLD 1 or greater COPD have an adverse quality of life as compared to those without airways obstruction, differences in scores being greater for the physical rather than emotional domains. Occupational exposure to VGDF also appears to adversely affect quality of life estimates.
Introduction COPD is associated with a considerable degree of morbidity and mortality and has been shown to adversely affect quality of life. One of the aims of a large epidemiological study of COPD and occupation in Sheffield was to evaluate quality of life. Having previously presented data from our initial survey using the EQ-5D tool and self-reported COPD 1 , we now present data from the follow up phase of the population based study using the more detailed quality of life estimate SF-36v2 and COPD defined by spirometry.Methods A random population sample of 4000 Sheffield residents aged over 55 years was approached for study in 2007, along with a supplemental sample of 209 people with likely COPD recruited from a hospital physiology department. A detailed questionnaire recorded demographics, respiratory symptoms and diagnoses, smoking and occupational exposures. A proportion were re-visited in 2009e2010 for further spirometry and quality of life measure using the SF-36v2, which consists of 36 questions, divided into 8 domains, scores being converted to a scale from 0 to 100, the higher score indicating better health. Results 549 people participated in the follow up phase, of whom 361 completed the SF-36v2. Abstract P1 Figure 1 shows mean scores for each of four different categories relating to COPD (defined by GOLD level 1 spirometry) and ever exposure to vapours, gases, dust and fumes (VGDF) in the workplace. In all domains, the group with airways obstruction has lower mean values than those without, and those who also report exposure to VDGF at work have further reductions (p<0.05). Of the 103 people in this group who have airways obstruction, those who also self-report a diagnosis of COPD (n¼49) have significantly worse (p<0.05) quality of life than those who have no self-reported diagnosis.Abstract P1 Figure 1 Conclusions Those with GOLD 1 or greater COPD have an adverse quality of life as compared to those without airways obstruction, differences in scores being greater for the physical rather than emotional domains. Occupational exposure to VGDF also appears to adversely affect quality of life estimates.
Idiopathic Pulmonary Fibrosis (IPF) is a progressive, debilitating interstitial lung disease of unknown aetiology that results in irreversible scarring of the lungs. Patients develop impaired oxygen exchange and subsequent functional limitations including dyspnoea, hypoxia and fatigue. Patients' fear of breathlessness leads to avoidance of physical activity yet, exercise is crucial to maintain health, strength, and mobility. Pulmonary rehabilitation is advocated for IPF patients but access to such programmes is difficult and restricted. Methods The Irish Lung Fibrosis Association (ILFA) in collaboration with the physiotherapy department at the Mater Misericordiae University Hospital developed the 2000 Steps a Day Challenge as a new and innovative home-based exercise programme for IPF patients. The 2000 Steps a Day pack includes a pedometer, guidance and a diary to progress the step programme, and a Contract for Success to encourage commitment. Positive language and inspirational messages were used to motivate patients to make it part of their daily routine and reassure and support those experiencing setbacks. The programme was piloted by 15 ambulatory patients (11 male: 4 female) for 4-weeks. 10/15 patients required supplementary oxygen, 6/15 patients were on the lung transplant list and 3/15 patients were post-lung transplant. Patients were asked to record their baseline daily step count for 1-week, to gradually incorporate an additional 2000 steps (equivalent to 1 mile of walking) into their daily routine, and to complete a questionnaire on the suitability of the new exercise programme. Results 12/15 patients completed the pilot phase and successfully added at least 2000 steps extra to their daily routine. 10/12 patients completed the questionnaire. 90% said the written materials were clear and understandable, 70% said the programme was easy to incorporate into their lives, 80% were motivated to exercise every day, 90% considered the pedometer a good motivational tool, 70% found the diary practical, 80% reported improved confidence, 100% felt a sense of achievement after reaching their target, 100% would recommend the programme to another patient. To date, over 200 walking packs have been requested. The ILFA 2000 Steps a Day Challenge is a novel, safe, effective and achievable home-based exercise solution for IPF patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.